A private business has helped supercharge a controversial federal drug program. Patients and insurers have been left with big bills.
Category: Health and Human Services Department
-
Eli Lilly Chief Says He Will Fight for the FDA, Challenging RFK Jr.’s Stance
The health care giant’s David Ricks defended the agency’s role in reviewing data and ensuring drug safety.
-
Nursing Home Industry Wants Trump to Rescind Staffing Mandate
A Biden administration rule that imposed minimum rules on nursing levels may not survive, even though many homes lack enough workers to maintain residents’ care.
-
Drug Companies Face Hostility as They Hope for Allies Among Trump’s Health Picks
Robert F. Kennedy Jr. and other candidates for top health posts are at odds with the drug industry, setting the stage for tense battles over regulatory changes.
-
RFK Jr.’s Ideas on Big Pharma and Food Align With Some of Trump’s Biggest Critics
When it comes to weeding out corporate influence, Robert F. Kennedy Jr.’s ideas often align best with some of Trump’s loudest critics.
-
Dr Martin Makary Chosen to Head the FDA
A frequent Fox News commentator, Dr. Makary has a penchant for challenging the medical establishment, and stirred pandemic concerns with his views on Covid immunity and vaccine mandates.
-
Five Ways R.F.K. Jr. Could Undermine Lifesaving Childhood Vaccines
If he is confirmed as H.H.S. secretary, the longtime vaccine critic would be in a position to change the government’s immunization recommendations and delay the development of new vaccines.
-
Robert F. Kennedy Jr.’s Billion-Dollar Hit to Big Pharma
Donald Trump’s choice to run the Department of Health and Human Services spooked investors who worry what Kennedy would do.